@article{APS10723,
author = {Min Huang and Mei-yu Geng and Jian Ding},
title = {Antitumor pharmacological research in the era of personalized medicine},
journal = {Acta Pharmacologica Sinica},
volume = {43},
number = {12},
year = {2022},
keywords = {},
abstract = {Anticancer drug discovery has yielded unprecedented progress in recent decades, resulting in the approval of innovative treatment options for patients and the successful implementation of personalized medicine in clinical practice. This remarkable progress has also reshaped the research scope of pharmacological research. This article, as a tribute to cancer research at Shanghai Institute of Materia Medica in celebration of the institute’s 90th birthday, provides an overview of the conceptual revolution occurring in anticancer therapy, and summarizes our recent progress in the development of molecularly targeted therapeutics and exploration of new strategies in personalized medicine. With this review, we hope to provide a glimpse into how antitumor pharmacological researchers have embraced the new era of personalized medicine research and to propose a future path for anticancer drug discovery and pharmacological research.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/10723}
}